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ABSTRACT
OBJECTIVE: The objective of this selective EBM review is to determine whether or not
acupuncture is an effective treatment for acute migraines.
STUDY DESIGN: Review of three English language randomized controlled trials,
published between 2003 and 2012.
DATA SOURCES: Three randomized controlled trials published in peer reviewed
journals found using PubMed, Medline, and EBSCOhost.
OUTCOMES MEASURED: The outcomes measured included complete absence of
migraine pain, measured by Visual Analog Scale scores and a headache diary, and
progression to a fully formed migraine, measured by the Validated Pain Scale by Heller.
RESULTS: The studies by Li et al and Wang et al found a statistically significant number
of patients were pain free, 24 hours following acupuncture, compared to sham
acupuncture. The study by Melchart et al found statistically significant fewer patients
progressed to a full migraine, 48 hours following acupuncture, compared to a Sumatriptan
placebo.
CONCLUSIONS: The results showed acupuncture is an effective treatment for acute
migraines, as evidenced by a significant number of patients experiencing complete absence
of pain, or avoiding a full migraine after receiving acupuncture, as well as low numbers
needed to treat (NNT) for all three studies. Additional research is needed in order to
determine the type of acupuncture that is most effective in the treatment of migraines.
KEY WORDS: Migraine, acupuncture
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Introduction
Migraine headache is a common diagnosis, which impacts a patient both
professionally and socially. By definition, a migraine is a headache that is characterized by
unilateral location, pulsating quality, moderate to severe intensity, and associated
symptoms of photophobia, phonophobia, nausea and vomiting1. Migraine headaches are a
result of the brain being particularly sensitive to environmental and sensory stimuli.
Although the exact pathophysiology of migraines is unknown, it is believed that this
sensory oversensitivity is due to a dysfunction in the monoaminergic sensory control
systems in the brainstem and thalamus. Dopamine and Serotonin are also both believed to
play a role in migraine headaches2.
Migraines are the second most common cause of headache, with approximately
15% of women and 6% of men experiencing a migraine in a one year period2. In 2010
there were 1.2 million visits to emergency rooms in the United States for migraines3. This
prevalence places a financial burden on both the health care system and employers of
people who suffer from migraine headaches. It is estimated that 2-3 billion dollars are
spent on the treatment of migraines annually and that US employers lose an additional 13
billion dollars in lost labor due to migraine headaches each year4.
Symptoms of migraines include a unilateral throbbing headache, anorexia, nausea,
vomiting, photophobia, phonophobia, osmophobia, cognitive impairment, and blurring of
vision5. A migraine may or may not be preceded by an aura of transient neurologic
symptoms. The most common form of an aura is a visual alteration. Visual alterations
include hemianopic field defects, scotomas, and scintillations that spread peripherally6.

Knab, Acupuncture for Acute Migraine

2

Treatment of acute migraine headaches focuses on symptom relief. Symptomatic
relief is provided by simple analgesics, such as Acetaminophen and NSAIDs, Ergotamines,
Triptans and antiemetics. In some cases Opioid analgesics are required if other treatment
modalities fail to relieve pain5. These medications are typically effective at alleviating or
getting rid of acute migraine pain, however, some patients are unable to take these
medications due to underlying medical conditions or interactions with other medications,
while others would prefer an alternative non-medicinal form of therapy.
An alternative to pharmacologic therapy for the relief of acute migraine pain is
acupuncture. Acupuncture is an oriental medical practice that uses needles to stimulate
specific anatomic points, in order to promote proper flow of energy, thereby treating illness
and promoting health. Acupuncture is performed with four to fifteen thin, solid, stainless
steel needles that are inserted into selected acupuncture points for 10-30 minutes. These
needles are stimulated manually or with electricity or heat7.

OBJECTIVE
The objective of this selective EBM review is to determine whether or not
acupuncture is an effective treatment for acute migraines.

METHODS:
The studies used in this systematic review include three randomized, placebo
controlled clinical trials, which were selected based on specific criteria. The population
studied included both males and females, 18-65 years old, who were diagnosed with
migraine headaches. The intervention used in each of the studies was acupuncture. In the
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studies by Li et al and Wang et al, comparisons were made between the treatment group, in
which patients received acupuncture, and the control group, in which patients received
sham acupuncture8,1. In the study by Melchart et al, a 1 ml NaCl injection, which was a
visually matched placebo for Sumitriptan was used as the control intervention9. Outcomes
measured included complete pain relief 24 hours after treatment with acupuncture and
progression to a full migraine 48 hours after treatment.
All studies were published in the English language in peer-reviewed journals.
Research for each study was done by the author via PubMed, Medline, and EBSCOhost
using the keywords “migraine” and “acupuncture”. Studies were selected based on
relevance to the clinical question and the inclusion of patient oriented outcomes. Inclusion
criteria for the studies included randomized controlled trials, published between 2003 and
2012, which used acupuncture as an intervention for acute migraine headaches. Exclusion
criteria included patients under the age 18 and use of the intervention for prophylaxis of
migraines. Statistics used in this review included p-values, numbers needed to treat
(NNT), relative risk reduction (RRR), absolute risk reduction (ARR), and number needed
to harm (NNH), which were calculated by the author using the dichotomous data found in
each study. Table 1 displays the characteristics and demographics of the included studies.

Table 1: Demographics & Characteristics of included studies
Study

Type

Li et al8
(2009)

Single
Blind,
Placebo
controlled
RCT

#
Pts
175

Age
(yrs)
1865

Inclusion
Criteria
Men and
women with
a diagnosis
of migraine
for 1 year
with one or
more

Exclusion Criteria W/
D
Subarachnoid
12
hemorrhage,
cerebral
hemorrhage,
cerebral
embolism,
cerebral

Interventions
Verum
acupuncture
vs. sham
acupuncture
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migraines per
month during
the last 3
months.

Melchart
et al9
(2003)

Placebo
controlled
RCT

179

1865

Wang et
Single
al1 (2012) Blind,
Placebo
controlled
RCT

150

1865

thrombosis,
vascular
malformation,
bleeding
disorders, or
allergies.
Men and
Ischemic heart
women with disease or other
a diagnosis
vascular diseases,
of migraine
HTN, asthma,
for 3 years,
blood coagulation
with a
disorders or other
frequency of neurological or
at least
psychiatric
2/month,
disorders, use of
who rated the psychoactive
intensity of
drugs, history of
their
drug or alcohol
migraine as
abuse, pregnancy
mild or less. or lactation.

4

Men and
women with
a history of
migraine for
more than 1
year, with at
least 1
migraine
attack during
the last 4
weeks.

0

Other headache
10
disorders,
pregnancy,
lactation,
psychosis,
immunodeficient
patients, bleeding
disorders, or
allergies.
Prophylaxis with
acupuncture or
drugs in the past 3
months.

Verum
acupuncture
vs
Sumatriptan
visually
matched
placebo, 1 ml
NaCl
solution
injection.

Verum
acupuncture
vs. sham
acupuncture

OUTCOME MEASURES
The outcome measures in each of the studies focused on the progression or
resolution of migraine pain. The studies by Li et al, and Wang et al measured whether or
not complete pain relief occurred 24 hours after the intervention. The study by Li et al
measured pain relief by asking patients to keep a headache diary and record the time when
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the pain started to ease and note whether or not there was complete pain relief 24 hours
after treatment8. The study by Wang et al measured if complete pain relief occurred 24
hours after treatment, by using Visual Analog Scale (VAS) scores for pain (0=no pain,
10=worst pain)1. The study by Melchart et al measured whether or not the patient
progressed to a full migraine. This measurement was based on the Validated Pain Scale by
Heller, on which a score greater than 30 was considered to be a full migraine9.

RESULTS
The three studies used in this review examined the effect of acupuncture on pain
relief in patients experiencing an acute migraine headache. Each of the studies contained
dichotomous data, which could be used to calculate RRR, ARR, and NNT. Two of the
studies examined the efficacy of acupuncture in the achievement of complete pain relief
within 24 hours. The third study examined if acupuncture was effective at stopping the
progression of a mild migraine to a fully developed migraine headache.
In the study by Li et al, 175 patients with an acute migraine were randomly
assigned to either the verum acupuncture group (n=58), sham acupuncture group one
(n=60) or sham acupuncture group two (n=57)8. For the purpose of this review sham
acupuncture group two was excluded. The patients assigned to the acupuncture group
received needling in genuine acupoints, whereas the patients in the two sham acupuncture
groups received needling in two different sets of predesignated nonacupoints. This was a
single blinded study, in which the participants were unaware of the intervention they were
receiving, however the clinician performing the acupuncture was not blinded. 12 of the
patients enrolled in the study did not complete the study, 5 of these patients were lost to
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follow-up, 4 withdrew due to adverse events, and 3 withdrew for unclear reasons or
protocol violations. In total 6.9% of subjects were lost to follow-up. Outcomes were
measured with intention to treat analysis8.
Each participant received 1 session of either verum or sham acupuncture and was
followed for a 24 hour period following the intervention. Each patient was asked to keep a
headache diary and note if they experienced complete pain relief 24 hours after receiving
the intervention. The study found that 40.7% of patients in the acupuncture group and
16.7% of patients in the control group achieved complete pain relief 24 hours after the
intervention. This represents a statistically significant difference (p<0.05) in the
percentage of patients who achieved complete pain relief 24 hours following the
intervention8. This data demonstrated a relative risk reduction (RRR) of 143.7% and an
absolute risk reduction (ARR) of 24.0%. The number needed to treat (NNT) was 5,
meaning that 5 patients needed to be treated with acupuncture in order for 1 more patient to
experience complete pain relief than the control 24 hours after treatment (Table 2).

Table 2: Percent of patients pain free 24 hours after treatment and NNT
% Pain free
% Pain free
pRRR* ARR* NNT*
(Acupuncture group) (control group) value
Li et al8
40.7%
16.7%
<0.05 1.437
24.0% 5
1
Wang et al 20.0%
9.3%
0.001 1.151
10.7% 10
*RRR=relative risk reduction, ARR=absolute risk reduction, NNT=numbers needed to
treat

In the study by Wang et al, 150 patients with an acute migraines were randomly
assigned to either the verum acupuncture (n=75) or sham acupuncture group (n=75). 10
patients, 3 from the verum acupuncture group, and 7 from the sham acupuncture group,
withdrew from the study due to fear of needling or time restrictions. In total 6.7% of
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subjects were lost and outcomes in the study were analyzed with the intention to treat
method1.
Each patient in the study received 30 minutes of either acupuncture or sham
acupuncture and recorded their pain using Visual Analog Scale (VAS) scores, in which
0=no pain and 10=worst pain. 20% of patients in the acupuncture group and 9.3% of
patients in the sham acupuncture group were pain free (VAS score of 0) 24 hours after the
intervention. There was a statistically significant difference (p=0.001) in the percentage of
patients who were pain free following the two interventions1. The data demonstrated a
relative risk reduction (RRR) of 115.1% and an absolute risk reduction (ARR) of 10.7%.
The NNT in this study was 10 (Table 2).
The study by Melchart et al looked at the number of patients who avoided a fully
developed migraine 48 hours following the intervention. In this study, 179 patients were
randomly assigned to the acupuncture group (n=60), the group receiving Sumatriptan
(n=58), or a Sumatriptan visually matched placebo (n=61). In order to be included in the
study patients needed to report their initial pain as a 20 or less (Table 1). There were no
withdrawals from this study9. For the purpose of this review the group receiving
Sumatriptan was excluded.
48 hours after receiving the intervention, patients were asked to assess headache
intensity, using the validated pain scale by Heller. The validated pain scale by Heller is a
50 point categorical scale, on which 0=no pain and 50=most severe pain. A score greater
than 30 represented a fully developed migraine. A full migraine was prevented in 35% of
the patients receiving acupuncture and 18% of the patients receiving the placebo injection.
There was a statistically significant difference (p=0.028) between acupuncture and the
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placebo9. This data demonstrated a relative risk reduction (RRR) of 94% and an absolute
risk reduction (ARR) of 17%. The NNT in this study was 6, meaning that 6 patients
needed to be treated with acupuncture in order for 1 more patient to avoid progression to a
fully developed migraine than with the control (Table 3). There was a 95% confidence
interval for the estimate of the treatment effect7.
Table 3: Percent of patients who avoided a fully developed migraine 48 hours after
treatment and NNT
% of patients who
% of patients who
pRRR* ARR* NNT*
avoided a fully
avoided a fully
value
developed migraine developed migraine
(acupuncture group) (control group)
Melchart 35%
18%
0.028 94%
17%
6
9
et al
*RRR=relative risk reduction, ARR=absolute risk reduction, NNT=numbers needed to
treat

In the study by Li et al, adverse events included fainting during needling, nausea
and vomiting, mild bleeding and hematoma. These adverse effects were experienced by 9
people in the study, however it was not specified which treatment group these individuals
belonged to8. In the study by Wang et al, adverse effects reported included bleeding after
needle removal and fatigue. 4% of patients in the acupuncture group and 5.3% of patients
in the control group experienced an adverse effect1. The number needed to harm for this
study was -76, meaning that for every 76 patients who were treated with acupuncture, 1
fewer patient would experience an adverse effect than the control (table 4). In the study
by Melchart et al, adverse effects included elevated blood pressure, dizziness, vertigo, and
other non-specified adverse effects. 23.3% of patients in the acupuncture group
experienced an adverse effect and 16.4% of patients receiving the placebo experienced an
adverse effect9. The number needed to harm (NNH) for this study was 15, meaning that
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for every 15 patients who were treated with acupuncture, 1 more patient would experience
and adverse effect than compared to the control (table 4).

Table 4: Percent of patients with an adverse effect and NNH

Wang et al1
Melchart et al9

Percentage of patients who
experienced an adverse event
(acupuncture group)
4.0%
23.3%

Percentage of patients who
experienced an adverse event
(control group)
5.3%
16.4%

NNH

-76
15

DISCUSSION
The randomized controlled trials in this review examine acupuncture as an
alternative form of treating acute migraine pain. With statistical significance of p<0.05,
all three of the studies demonstrated that acupuncture is an effective treatment for an acute
migraine. Two of the studies showed that acupuncture effectively eliminated migraine pain
within 24 hours as compared to sham acupuncture. The third study showed that
acupuncture was effective at preventing a fully developed migraine headache compared to
a placebo for a commonly used migraine medication.
There are several limitations in this review. One limitation is that the studies had a
relatively small sample size making it more difficult to generalize the results to the
majority of patients. Another limitation was this review only examined studies of
individuals aged 18-65 and migraines can occur at any age. Another limitation was that
the studies were only single blinded, since the clinicians who were performing the
acupuncture needed to know if they were giving the experimental or control intervention.
Lastly, it is hypothesized that sham acupuncture may produce certain effects on pain relief
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regardless of the sham point selection. This is known as a “DeQi” sensation and it may
have interfered with testing in the control groups in the studies by Li and Wang1. A
limitation that this author experienced when searching for relevant studies was that there
are many studies that examine the efficacy of acupuncture for the prophylaxis of migraines
and not the actual treatment of an acute migraine. Another limitation was that due to the
oriental nature of acupuncture many of the published studies were not in the English
language.
Acupuncture is becoming increasingly popular in Western medicine, with more
than 18,000 licensed acupuncture practitioners and more than 3,500 physician
acupuncturists in the United States7. Acupuncture is currently used to treat a wide variety
of conditions, including chronic pain, osteoarthritis, back pain, and the management of
postoperative pain, dental pain, nausea and vomiting. Many insurance companies will pay
for acupuncture if the patient has a diagnosis of migraines, however, companies typically
will only cover 12-20 visits per year. The cost of acupuncture varies from $50-$150 per
session10.
Adverse effects to acupuncture are generally mild, and include pain, bleeding,
fatigue, nausea, and dizziness. Serious adverse effects, such as pneumothorax or vascular
injuries are rare11. There are no absolute contraindications for acupuncture, however it
should be avoided in pregnant patients, malignant tumors, and patients with bleeding
disorders or patients on anticoagulant therapy12.

CONCLUSION
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The three randomized control trials in this review provide statistically significant
evidence that acupuncture is an effective treatment for acute migraine. According to these
results acupuncture may be a good treatment option for patients who are unable to achieve
migraine relief with traditional pharmacologic therapy or who want an alternative therapy
option. Further research is warranted to evaluate which acupoints are most beneficial in
the treatment of migraines and future studies are needed to determine if acupuncture is a
cost effective form of therapy. Only one of the RCTs used in this review compared the
efficacy of acupuncture to current pharmacologic therapies for migraines, therefore,
additional research is needed to see how acupuncture compares to pharmacologic therapy
for migraine headaches. Currently research is being done to assess the use of acupuncture
as a prophylactic treatment of migraine headaches.
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